| Product Code: ETC9966194 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Fluid Biopsy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Fluid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Fluid Biopsy Market - Industry Life Cycle |
3.4 United States (US) Fluid Biopsy Market - Porter's Five Forces |
3.5 United States (US) Fluid Biopsy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 United States (US) Fluid Biopsy Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 United States (US) Fluid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the US population |
4.2.2 Technological advancements in liquid biopsy techniques and tools |
4.2.3 Growing adoption of personalized medicine and targeted therapies in cancer treatment |
4.3 Market Restraints |
4.3.1 High cost associated with liquid biopsy testing |
4.3.2 Regulatory challenges and uncertainty in the approval process |
4.3.3 Limited awareness and understanding of liquid biopsy among healthcare providers and patients |
5 United States (US) Fluid Biopsy Market Trends |
6 United States (US) Fluid Biopsy Market, By Types |
6.1 United States (US) Fluid Biopsy Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Fluid Biopsy Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 United States (US) Fluid Biopsy Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 United States (US) Fluid Biopsy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 United States (US) Fluid Biopsy Market Revenues & Volume, By Colorectal, 2021- 2031F |
6.1.6 United States (US) Fluid Biopsy Market Revenues & Volume, By Other, 2021- 2031F |
6.2 United States (US) Fluid Biopsy Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Fluid Biopsy Market Revenues & Volume, By Circulating Tumor Cells, 2021- 2031F |
6.2.3 United States (US) Fluid Biopsy Market Revenues & Volume, By Circulating Tumor DNA, 2021- 2031F |
6.2.4 United States (US) Fluid Biopsy Market Revenues & Volume, By Cell-free DNA, 2021- 2031F |
7 United States (US) Fluid Biopsy Market Import-Export Trade Statistics |
7.1 United States (US) Fluid Biopsy Market Export to Major Countries |
7.2 United States (US) Fluid Biopsy Market Imports from Major Countries |
8 United States (US) Fluid Biopsy Market Key Performance Indicators |
8.1 Average turnaround time for liquid biopsy test results |
8.2 Number of research studies and clinical trials utilizing liquid biopsy in the US |
8.3 Adoption rate of liquid biopsy tests by oncologists and cancer treatment centers |
9 United States (US) Fluid Biopsy Market - Opportunity Assessment |
9.1 United States (US) Fluid Biopsy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 United States (US) Fluid Biopsy Market Opportunity Assessment, By Type, 2021 & 2031F |
10 United States (US) Fluid Biopsy Market - Competitive Landscape |
10.1 United States (US) Fluid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Fluid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here